Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials

@article{Martens2018IntroducingWA,
  title={Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials},
  author={Marvin Martens and Tim Verbruggen and Penny Nymark and Roland C Grafstr{\"o}m and Lyle D. Burgoon and Hristo T. Aladjov and Fernando Torres And{\'o}n and Chris T. A. Evelo and Egon Willighagen},
  journal={Frontiers in Genetics},
  year={2018},
  volume={9}
}
A paradigm shift is taking place in risk assessment to replace animal models, reduce the number of economic resources, and refine the methodologies to test the growing number of chemicals and nanomaterials. Therefore, approaches such as transcriptomics, proteomics, and metabolomics have become valuable tools in toxicological research, and are finding their way into regulatory toxicity. One promising framework to bridge the gap between the molecular-level measurements and risk assessment is the… 

Figures from this paper

Molecular annotation of AOPs guides the development of the next generation mechanistic chemical safety assessment and new approach methods
TLDR
This work developed a multi-step strategy to annotate the AOPs relevant to human health risk assessment and shows that this framework successfully highlights relevant adverse outcomes for chemical exposures with strong in vitro and in vivo convergence, supporting chemical grouping and other data-driven approaches.
Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale
TLDR
A brief overview of the AOP framework and its application to nanotoxicology, tools for developing AOPs and the role of toxicogenomics are detailed, and various AOP's of relevance to inhalation toxicity of nanomaterials that are currently under various stages of development are summarized.
Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment
TLDR
This review presents the state-of-the-art of data modelling applied to transcriptomics data in TGx, and shows how the benchmark dose (BMD) analysis can be applied to TGx data.
The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework
TLDR
The recent semantic mapping efforts for the AOP-DB are described, and how this process facilitates the integration of Aop-DB data with other toxicologically relevant datasets through a use case example.
Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.
TLDR
An innovation funnel enriched with safety methods is ultimately proposed under the central aim of promoting rigorous nanomaterials innovation, including guidance to the selection of specific NAMs in the eight categories.
Transcriptomics analysis of hepatotoxicity induced by the pesticides imazalil, thiacloprid and clothianidin alone or in binary mixtures in a 28-day study in female Wistar rats
TLDR
A transcriptomics analysis of rat livers by means of total RNA sequencing brought new insight into the hepatotoxicity mechanisms of IMZ, THI, and CTD and their mixtures.
Cross-Model Comparison of Transcriptomic Dose-Response of Short-Chain Chlorinated Paraffins.
TLDR
A cross-model comparison of concentration-dependent transcriptomics represents a promising approach to assess and prioritize SCCPs and demonstrated model-specific responses, such as xenobiotic metabolism that may be mediated by different nuclear receptor-mediated pathways between HepG2 cells and ZFEs.
Adverse Outcome Pathways for Developmental Toxicity
  • J. M. Rogers
  • Biology
    Health Impacts of Developmental Exposure to Environmental Chemicals
  • 2019
TLDR
This chapter will briefly recount some historical milestones in teratology and articulate several illustrative examples of research on mechanisms of normal and abnormal development that have served to provide the bricks and mortar from which AOPs for developmental toxicity can be built.
Correlation Analysis of Variables From the Atherosclerosis Risk in Communities Study
The need to test chemicals in a timely and cost-effective manner has driven the development of new alternative methods (NAMs) that utilize in silico and in vitro approaches for toxicity prediction.
...
...

References

SHOWING 1-10 OF 56 REFERENCES
The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment
TLDR
An overview of ecological risk assessment process and a perspective on how high content molecular-level datasets can support the future of assessment procedures through the AOP framework are developed.
The adverse outcome pathway concept: a pragmatic tool in toxicology.
The challenge of the application of 'omics technologies in chemicals risk assessment: Background and outlook.
A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions
TLDR
A 6-step workflow that integrated diverse types of toxicology data into a novel AOP scheme for pulmonary fibrosis, coupled with a network of functional elements, resulting in a novel, open-source AOP-linked molecular pathway.
Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment
TLDR
A framework designed for this purpose, the adverse outcome pathway (AOP), is discussed, a conceptual construct that portrays existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment.
Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.
Adverse outcome pathways: opportunities, limitations and open questions
TLDR
The history of the AOP concept and its most prominent strengths are discussed, including the advantages of a formalized approach, the systematic collection of weight of evidence, the linkage of mechanisms to apical end points, the examination of the plausibility of epidemiological data, the identification of critical knowledge gaps and the design of mechanistic test methods.
Adverse outcome pathways: a concise introduction for toxicologists
TLDR
The present paper provides a synopsis of the main principles related to the AOP framework for the toxicologist less familiar with this area, followed by two case studies relevant for human toxicology and ecotoxicology.
Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver.
TLDR
A method for integrating publicly available data in order to generate computationally predicted AOP (cpAOP) scaffolds, which can be leveraged by domain experts to shorten the time for formal AOP development.
...
...